Logo image of JUNE

JUNEE LTD (JUNE) Stock Fundamental Analysis

NASDAQ:JUNE - Nasdaq - VGG5294K1104 - Common Stock - Currency: USD

10.82  +0.06 (+0.56%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to JUNE. JUNE was compared to 73 industry peers in the Diversified Consumer Services industry. While JUNE has a great health rating, there are worries on its profitability. JUNE does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

JUNE had negative earnings in the past year.
JUNE had a negative operating cash flow in the past year.
JUNE Yearly Net Income VS EBIT VS OCF VS FCFJUNE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 500K -500K -1M

1.2 Ratios

With a Return On Assets value of -13.56%, JUNE is not doing good in the industry: 61.64% of the companies in the same industry are doing better.
JUNE has a Return On Equity (-15.58%) which is in line with its industry peers.
Industry RankSector Rank
ROA -13.56%
ROE -15.58%
ROIC N/A
ROA(3y)-3.75%
ROA(5y)N/A
ROE(3y)-4.74%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
JUNE Yearly ROA, ROE, ROICJUNE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 10 -10 20

1.3 Margins

The Gross Margin of JUNE (26.83%) is worse than 67.12% of its industry peers.
JUNE's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for JUNE so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 26.83%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y14.38%
GM growth 5YN/A
JUNE Yearly Profit, Operating, Gross MarginsJUNE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 20 -20

7

2. Health

2.1 Basic Checks

JUNE does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, JUNE has less shares outstanding
Compared to 1 year ago, JUNE has an improved debt to assets ratio.
JUNE Yearly Shares OutstandingJUNE Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 5M 10M
JUNE Yearly Total Debt VS Total AssetsJUNE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 2M 4M 6M 8M

2.2 Solvency

An Altman-Z score of 81.51 indicates that JUNE is not in any danger for bankruptcy at the moment.
The Altman-Z score of JUNE (81.51) is better than 100.00% of its industry peers.
JUNE has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
JUNE has a Debt to Equity ratio of 0.01. This is in the better half of the industry: JUNE outperforms 65.75% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z 81.51
ROIC/WACCN/A
WACC9.11%
JUNE Yearly LT Debt VS Equity VS FCFJUNE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 2M 4M 6M

2.3 Liquidity

A Current Ratio of 8.25 indicates that JUNE has no problem at all paying its short term obligations.
JUNE's Current ratio of 8.25 is amongst the best of the industry. JUNE outperforms 95.89% of its industry peers.
A Quick Ratio of 8.25 indicates that JUNE has no problem at all paying its short term obligations.
The Quick ratio of JUNE (8.25) is better than 95.89% of its industry peers.
Industry RankSector Rank
Current Ratio 8.25
Quick Ratio 8.25
JUNE Yearly Current Assets VS Current LiabilitesJUNE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 2M 4M 6M

0

3. Growth

3.1 Past

JUNE shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -7200.00%.
The Revenue for JUNE has decreased by -50.14% in the past year. This is quite bad
Measured over the past years, JUNE shows a very negative growth in Revenue. The Revenue has been decreasing by -22.76% on average per year.
EPS 1Y (TTM)-7200%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2660%
Revenue 1Y (TTM)-50.14%
Revenue growth 3Y-22.76%
Revenue growth 5YN/A
Sales Q2Q%-52.72%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
JUNE Yearly Revenue VS EstimatesJUNE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2M 4M 6M 8M

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for JUNE. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
JUNE Price Earnings VS Forward Price EarningsJUNE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
JUNE Per share dataJUNE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for JUNE!.
Industry RankSector Rank
Dividend Yield N/A

JUNEE LTD

NASDAQ:JUNE (5/22/2025, 12:08:19 PM)

10.82

+0.06 (+0.56%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryDiversified Consumer Services
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.35%
Inst Owner Change1569.09%
Ins Owners4.05%
Ins Owner ChangeN/A
Market Cap140.77M
AnalystsN/A
Price TargetN/A
Short Float %28.11%
Short Ratio0.67
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 30.83
P/FCF N/A
P/OCF N/A
P/B 20.21
P/tB 20.21
EV/EBITDA N/A
EPS(TTM)-0.09
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.06
FCFYN/A
OCF(TTM)-0.06
OCFYN/A
SpS0.35
BVpS0.54
TBVpS0.54
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -13.56%
ROE -15.58%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 26.83%
FCFM N/A
ROA(3y)-3.75%
ROA(5y)N/A
ROE(3y)-4.74%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y14.38%
GM growth 5YN/A
F-Score4
Asset Turnover0.57
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 61.32%
Cap/Sales 0.14%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 8.25
Quick Ratio 8.25
Altman-Z 81.51
F-Score4
WACC9.11%
ROIC/WACCN/A
Cap/Depr(3y)87.22%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.19%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-7200%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2660%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-50.14%
Revenue growth 3Y-22.76%
Revenue growth 5YN/A
Sales Q2Q%-52.72%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-466.6%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-2585.9%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1766.74%
OCF growth 3YN/A
OCF growth 5YN/A